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Urea denaturationAbstract Albumin is a globular and un-glycosylated multifunctional plasma protein and thus cor-
related with several human diseases. Owing to esterase contamination, albumin levels are usually
misleading. In this study, we propose methodical accuracy for albumin estimation taking healthy
and ﬁbrotic rats. Liver ﬁbrosis in rats was generated by N0-Nitrosodimethylamine (NDMA)
(10 mg/kg body weight) within three weeks followed by its conﬁrmation through H&E and immu-
nohistochemical staining for a-SMA expression. Animal sera were screened by native polyacryl-
amide gel electrophoresis (native-PAGE) (7.5%). In-gel esterase-like albumin activity was
detected using a- and b-naphthyl acetate (5.58 · 103 mM; pH 7.5) as substrate. Sera albumin
was puriﬁed from unstained PA gel-slices through electroelution. Subsequent to conformation of
albumin purity by its molecular weight determination using SDS–PAGE (10%) and peptide mass
ﬁngerprinting by MALDI-TOF-MS, samples were treated with different concentrations of urea.
Urea-treated albumins were screened for esterase activity, conformational change and, albumin lev-
els by immunoblotting. Our results demonstrate that esterase-like albumin activity in rat sera albu-
min is located in domain-III. The esterase-like activity remains detectable up to 4 M urea, which
diminishes with increasing urea concentrations. Further, immunoblotting of urea-treated albumin
samples displays a signiﬁcant decline in puriﬁed protein bands, indicating hypoalbuminemia duringand its
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putative role as non-invasive biomarker of hhepatic ﬁbrosis in rats. In conclusion, the present approach of albumin separation and estimation is
of potential interest and may be recommended for diagnostic purposes.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Albumin is a 65–67 kD globular, un-glycosylated and the most
abundant multifunctional plasma protein in mammals. It is
involved in many vital physiological functions like maintenance
of plasma oncotic pressure and pH and, regulation of the trans-
port of ﬂuids across the capillary membrane etc. Besides, the
protein is a major carrier of endogenousmolecules, metabolites,
vitamins, fatty acids, bilirubin, drugs and other xenobiotics into
the blood. Moreover, albumin has been reported as the most
important antioxidant substance in plasma (Roche et al., 2008).
Published literature on human serum albumin (HSA) sug-
gests that it contains at least two distinct binding sites; site-I
for the binding of bulky heterocyclic molecule with centrally
located negative charge (like a large number of drugs) and
site-II, which binds aromatic carboxylic acids with hydrophobic
centers (Sudlow et al., 1975, 1976). An interesting attribute
of HSA is that it also possess esterase-like activity with
p-nitrophenol (Means and Bender, 1975), a- & b-naphthyl ace-
tate (Casida and Augustinsson, 1959; Morikawa et al., 1979;
Ahmad et al., 2012), nicotinate esters (Salvi et al., 1997), aspirin
(Rainsford et al., 1980), ketoprofen glucuronide (Dubois-Presle
et al., 1995), carprofen acylglucuronide (Georges et al., 2000),
cyclophosphamide (Kwon et al., 1987) and a large number of
long and short chain fatty acid esters (Tove, 1962). This ester-
ase-like activity of sera albumin has been endorsed to the pres-
ence of arginine and tyrosine residues at 410 and 411 positions
(Watanabe et al., 2000). This has been conﬁrmed that esterase-
like activity of sera albumin is inhibited by various drugs and
actually the acetylation of lysine residues results in the inhibition
of esterase-like activity of sera albumin (Lockridge et al., 2008).
Structural and functional impairments in albumin are
attributed to various pathophysiological conditions like diabe-
tes (Doweiko and Bistrain, 1994), osteoarthritis (Ahmad et al.,
2011a) and advanced liver diseases (Zoli et al., 1991; Sugimura
et al., 1994). Due to esterase–albumin complex formation in
these pathologies, use of albumin as non-invasive marker
may be misleading. However, in many of the liver diseases
plasma levels of albumin are reported to decline due to its
reduced synthesis and oxidative modiﬁcations that result in
its altered binding with bilirubin (Masood et al., 2002). One
of the major limitations to the clinical use of direct markers
of liver ﬁbrosis is that they are not routinely same in all set-
tings. As a result, simple and less expensive/cheap markers
are needed to be used more extensively in the clinical practice.
A reliable marker for hepatic ﬁbrosis must fulﬁll the follow-
ing criteria: (a) ability to quantify total mass of ﬁbrous tissue in
the liver; (b) ability to evaluate whether the liver is in a pro-
ﬁbrogenic or anti-ﬁbrogenic state and, (c) be sensitive enough
to determine the response of the liver to the treatments
designed to combat ﬁbrosis. Like many other pathologies,
there has been a debate on albumin levels in liver ﬁbrosis also,
where several researchers have reported an increase as well as
decrease in the levels of albumin during liver ﬁbrosis., Ahmad, R. In-gel detection of estera
epatic ﬁbrosis. Arabian Journal of Che(Rothschild et al., 1969; Panduro et al., 1990; Masood et al.,
2002; Sakaida et al., 2004; George, 2006). The discrepancy in
quantifying the exact levels of albumin may be attributed to
esterase–albumin complex and the sensitivity of site-I and -II
to bind with various molecules. Although there are other meth-
ods available for the detection of liver ﬁbrosis such as liver
biopsy examinations, transient elastography and several labo-
ratory tests, but still exists scarcity of non-invasive supportive
biomarker. Therefore, discovery of non-invasive biomarkers to
detect liver ﬁbrosis shall be a priority. In the present study, we
demonstrate a methodical procedure for albumin separation
and puriﬁcation free from esterase contamination in a mam-
malian model of liver ﬁbrosis utilizing the following proce-
dural steps: (1) In-gel detection of esterase-like albumin
activity, (2) puriﬁcation and further conﬁrmation of rat sera
albumin by electroelution and SDS–PAGE followed by MS
analysis respectively, (3) inhibition of esterase-like activity of
puriﬁed albumin by urea and, (4) conﬁrmation of sera albumin
by spectroscopy and later by immunoblotting to show its
accurate levels in healthy and ﬁbrotic rats.2. Materials and methods
2.1. Chemical
Acrylamide, bis-acrylamide, ammonium persulfate (APS),
TEMED, and N0-Nitrosodimethylamine (NDMA), were pro-
cured from Sigma–Aldrich. a- and b-naphthyl acetate, urea
and Tris buffer were purchased from SRL, India, goat anti-
mouse IgG-HRP conjugated antibody was purchased from
CALTAG Laboratories, Bangkok. a-smooth muscle actin (a-
SMA) antibodies were obtained from Trend Bio-products
Pvt. Ltd., India. All the other chemicals and reagents used
were of analytical grade.
2.2. Care and maintenance of animals
Healthy adult male albino rats Rattus norvegicus of Wistar
strain, weighing around 145 ± 10 g were used in the present
study. The animals were housed in well aerated polycarbonate
cages (12 h: 12 h = light: dark period) with proper humane
care and were fed regularly with commercial, sterilized diet
(Ashirwad Industries Pvt. Ltd., Mohali, Punjab, India) and
water available ad libitum. They were acclimatized for a week
before taking them for the treatment. All the experiments were
performed according to the guidelines of the Committee for
the Purpose of Control and Supervision of Experiments on
Animals (CPCSEA), India.
2.3. Induction of hepatic ﬁbrosis
Fibrosis was induced essentially as described previously
(Ahmad et al., 2009). Brieﬂy, the animals were divided intose-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
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received intraperitoneal injections of NDMA (diluted with
0.15 M NaCl) in doses of 10 mg kg1 body weight and the
other group, serving as control, received normal saline
0.15 M NaCl in doses of 10 mL kg1 i.p. The injections were
given on three consecutive days of each week for three weeks,
as described earlier (Ahmad et al., 2009). Five animals from
each group were anesthetized and sacriﬁced weekly on days
7, 14 and 21 from the start of treatment.
2.4. Histopathological and immunohistochemical analyses of
liver
Livers from sacriﬁced rats of each category were quickly
excised with sterilized scissors and forceps, washed with phos-
phate buffered saline (PBS) to remove other tissue debris. A
piece of liver tissue (from each animal) was ﬁxed in formalin
(10%) and processed for histopathological studies. The degree
of hepatic ﬁbrosis was monitored by Hematoxylin and Eosin
(H&E) staining and immunohistochemical localization of a-
smooth muscle actin in parafﬁn-embedded 5 lm thick serial
liver sections. Immunohistochemistry was carried out as
described in our previous reports (Ahmad et al., 2009). Stained
slides were examined and photographed under Nikon micro-
scope with an LCD attachment (Model: 80i).
2.5. Collection of sera and protein estimation
Blood was collected through cardiac puncture directly on
weekly basis i.e. on days 7, 14 and 21 from both treated as well
as control groups, from the beginning of experiment. Blood
samples were kept standing at RT for about an hour to ooze
out sera. Samples were centrifuged at 3000 rpm and 4 C for
8–10 min and the resulting clear, pale yellow colored sera were
either analyzed afresh or stored in aliquots at 20 C for fur-
ther biochemical investigation.
Protein concentration in the sera samples was determined
by following the protocol of Lowry et al. (1951) using Folin
phenol as coloring reagent and taking bovine serum albumin
(BSA) as the standard. Absorbance was taken at 660 nm on
a 10 UV–Visible GeneSys spectrophotometer.
2.6. In-gel staining of esterases
Vertical slab, non-denaturing 7.5% polyacrylamide gel
(100 · 80 · 1 mm) electrophoresis of collected sera samples
was carried out according to the protocol of Laemmli (1970),
with the modiﬁcation that samples, gels and running buffers
were lacking SDS. The gels contained acrylamide (Acrylamide:
bis-acrylamide = 29.2:0.8) and 10% glycerol. Equal quantities
of protein (8 lg) were loaded in each well and gels (in tripli-
cate) were run in buffer containing Tris (24 mM) and glycine
(194 mM) at room temperature. Following completion of elec-
trophoretic runs, one of the gels was stained with Coomassie
Brilliant Blue R-250 (CBB-R250) and destained overnight with
7% (v/v) glacial acetic acid. The gel, processed for esterase
localization was incubated in a reaction mixture containing
a, b-naphthyl acetate (5.58 · 103 mM, pH 7.5) as substrates
in the presence of Fast Blue RR at 25 C (Ahmad et al.,
2012). Upon development of the dark brown bands, indicating
esterase activity, the reaction was stopped by ﬁxing the gel inPlease cite this article in press as: Ahmad, A., Ahmad, R. In-gel detection of estera
putative role as non-invasive biomarker of hepatic ﬁbrosis. Arabian Journal of Che7% (v/v) glacial acetic acid for 20 min, followed by preserva-
tion of the gel in 5% (v/v) acetic acid prepared in 10%
methanol.
2.7. Puriﬁcation of sera albumin by electroelution
The zones (in the unstained gel), corresponding to albumin
bands in CBBR stained gels were cut and placed in Tris–glycine
(24 and 194 mM, respectively) as equilibration buffer at
20 C. Albumin puriﬁcation was carried out by electroelution
in Tris–glycine buffer of the same molarity at 4 C for 10 h.
Brieﬂy, for electroelution, gel pieces corresponding to the stack-
ing zone of albumin activity were excised in small pieces and
kept in dialysis tubing containing Tris–glycine buffer. Dialysis
bags, partially submerged in running buffer, were placed in a
horizontal electrophoretic assembly under the inﬂuence of
electric ﬁeld. Horizontal ﬂow of gel pieces in the tubing was
prevented by clamping in the middle of the dialysis tubing.
The current was allowed to ﬂow for 10 h at 4 C (based on
our pilot experiments) for complete elution of albumin from
the gel slices. The technique of electroelution is a routine and
established procedure in our laboratory.
2.8. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) of puriﬁed albumin
The albumin, thus puriﬁed, was conﬁrmed on 10% SDS–
PAGE essentially carried out according to the protocol of
Laemmli (1970). Silver staining of the gels was carried out
following the procedure of Nesterenko et al. (1994). Freshly
prepared chicken natural actomyosin (NAM) was used as
the molecular weight marker.
2.9. Albumin conﬁrmation by MALDI-TOF/TOF MS analysis
The protein band of interest (pAlb) was excised, diced into
small pieces and destained. The destaining solution was then
removed and the gel pieces were completely dried using aceto-
nitrile and Speedvac and reduced with 10 mM DTT (1 h at
56 C), alkylated with 55 mM iodoacetamide (45 min at room
temperature in the dark). In-gel trypsin (12.5 ng lL1 in
50 mM NH4HCO3 and 5 mM CaCl2) digestion was carried
out at 37 C overnight. The extraction of peptides after in-
gel digestion was performed with 50% acetonitrile and 0.1%
triﬂuoroacetic acid (TFA) and peptides obtained were mixed
with a-cyano-4-hydroxycinnamic acid (HCCA) matrix.
MALDI-TOF/TOF MS analysis was performed with
MALDI-TOF/TOF MS, Bruker Daltonics, Ultraﬂex III
instrument. Further analysis was carried out with Flex
Analysis Software for obtaining the peptide mass ﬁngerprint
(PMF). PMF and peptide fragments were examined with the
MASCOT program (www.matrixscience.com) using NCBInr/
Swiss-Prot sequence database.
2.10. Urea denaturation of puriﬁed albumin
The albumin puriﬁed from different treatment groups was
incubated with different urea concentrations i.e. 1, 2, 3, 3.5,
4, 4.5 and 5 M at room temperature for 12 h. Urea treated
albumin samples were analyzed through native-PAGE (run
in duplicate). The gels were stained with CBB-R250 andse-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
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naphthyl acetate and b-naphthyl acetate as substrates in the
presence of Fast Blue RR at 25 C (Ahmad et al., 2012). Once
the optimum visibility of bands was achieved, the reaction was
stopped by transferring the gels into 7% (v/v) glacial acetic
acid.
2.11. Spectral analysis of urea-treated albumin samples
Puriﬁed albumin (from all treatment categories) was treated
with variable concentrations of urea and incubated at room
temperature for 12 h. Spectral analysis of these samples was
carried out in the range of 250–300 nm. Tris–glycine, in addi-
tion to varying concentrations of urea i.e. 1, 2, 3, 3.5, 4, 4.5 and
5 M was used as the reference solution.
2.12. Albumin detection by Western immunoblotting
Western immunoblotting was performed according to themeth-
odology followed by Hasnain et al. (2004). Electrophoretic runs
of SDS-PA gels were equilibrated in Tris–glycine transfer buffer
(24 mM Tris, 194 mM glycine and 10% v/v methanol) for
25–30 min. The electrotransfer was carried out on PVDF mem-
branes (0.45 mm, BioRad, USA) at 125 V/200 mA for 2 h at
4 C. Subsequently, the membranes were washed thrice in PBS
(50 mM, pH 7.1) and treated with blotto (5% w/v non-fat dry
milk in PBS) for 1 h at room temperature. All the remaining
steps of incubation and washing were furnished in the same
blocking solution (i.e. blotto) containing 0.1% Tween-20
(PBS-T) (w/v). The blot was then incubated for 2 h in primary
antibody (rabbit anti-rat albumin antisera) diluted to 1 mg/
mlwith gentle shaking and, washed for 30 min with 3 changes
of PBS-T. The membrane was then treated with secondary anti-
body (horseradish peroxidase-conjugated goat anti-mouse IgG
immunoglobulins) diluted · 200 for 1 h at RT. Subsequently,
the membrane was washed thrice with PBS-T to remove the
unbound antibody. Chemiluminescence detection of peroxidase
activity was performed with LumiGLo Chemiluminescent kit
(KPA, USA) wherein the membrane was incubated with lumi-
nol reagents, exposed to sensitive USG ﬁlms for 5 min under
the dark, and developed.
2.13. Statistical analysis
The values of control and treated specimens were compared
and presented as mean ± SD. To test the signiﬁcant differ-
ences among the obtained values, Student’s t-test was applied
at P< 0.05.3. Results
Hepatic ﬁbrosis is a clinical condition resulting in greatly ham-
pered liver functioning, due to abnormal accumulation of
extracellular matrix proteins, in response to acute or chronic
hepatic injury. Variety of causes contributing to liver injury
includes viral infections, drugs, autoimmune, cholestasis and
some metabolic disorders (Ahmad and Ahmad, 2012). In the
present study, we have induced hepatic ﬁbrosis in rats by N0-
Nitrosodimethylamine (NDMA) and selected it as a disease
model to compare the obtained results of healthy with ﬁbroticPlease cite this article in press as: Ahmad, A., Ahmad, R. In-gel detection of estera
putative role as non-invasive biomarker of hepatic ﬁbrosis. Arabian Journal of Cheanimals. The ﬁbrosis thus generated perfectly imitates the
hepatic ﬁbrosis in humans.
3.1. Histopathology and immunohistochemical staining of liver
biopsies
Hematoxylin and Eosin stained liver biopsies demonstrate dis-
ruption in lobular architecture of the liver with severe neutro-
philic inﬁltration and patches of necrosis in the liver (Fig. 1A
and B). Conﬁrmation of the diseases was done through immu-
nohistochemical staining of the liver biopsies for a-smooth
muscle actin (a-SMA) localization, the diagnostic membrane
marker of activated hepatic stellate cells (HSCs). Liver section
showed numerous a-SMA positive HSCs (activated) in the
necrotic region of NDMA-induced ﬁbrotic liver (Fig. 1C and
D).
3.2. Electrophoretic proﬁling and identiﬁcation of major sera
fractions
Electrophoretic proﬁling of the sera of control and ﬁbrotic rats
under non-denatured conditions showed almost all the major
sera protein fractions, with a thick band of albumin toward
the anodal region (Fig. 2A).
3.3. In-gel detection of esterase-like albumin activity
Esterase-like albumin activity was observed in the control and
ﬁbrotic sera samples under native conditions when gels were
incubated with a-, and b-naphthyl acetate at room tempera-
ture. A thick band, corresponding to the stacking zone of albu-
min in CBB stained gels, was observed indicating esterase-like
albumin activity. Few low intensity minor bands of esterase
activity were also detected in the upper region of the gels
(Fig. 2B).
3.4. Studies on albumin puriﬁed through electroelution
Screening of the electroeluted albumin samples from sera of
ﬁbrotic and control rats was carried out under non-denaturing
and denaturing conditions to conﬁrm its purity. CBB stained
native gels demonstrate the presence of a single band corre-
sponding to albumin activity, while the same activity with sin-
gle band was also observed in substrate speciﬁc staining of
esterases suggesting that albumin retains its esterase-like activ-
ity even after puriﬁcation (Fig. 2C and E). Electrophoretic pro-
ﬁles under denatured conditions support the presence of a
single band in the electroeluted samples. GelPro analysis
reveals 66 kD band stacked corresponding to albumin in
SDS-PA gels (Fig. 3A). The purity of albumin, thus puriﬁed
by electroelution, was analyzed and conﬁrmed for rat serum
albumin by mass spectrometric peptide mass ﬁngerprint.
MALDI-TOF/MS spectrum derived from a representative
peptide is shown in Fig. 3B.
3.5. Effect of urea on sera esterase-like albumin activity
Albumin thus puriﬁed was treated with 1.0, 2.0, 3.0, 3.5, 4.0,
4.5 and 5.0 M urea concentration. The treated samples were
run on polyacrylamide gels and stained for esterase activity.se-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
Figure 1 Histopathology of liver sections. Histological conﬁrmation of NDMA-induced hepatic ﬁbrosis in rats. Hematoxylin and eosin
staining (A and B) of liver sections. (A) Control liver (10·) showing normal architecture, (B) Day-21 of NDMA treatment showing severe
hemorrhagic necrosis, congestion, lymphocyte inﬁltration (20·). Immunohistochemical staining of a-smooth muscle actin (a-SMA) (C and
D) during the pathogenesis of NDMA induced hepatic ﬁbrosis (C) control liver (10·) showing absence of a-SMA staining. (D) Intense
staining of a-SMA demonstrating widespread activation of hepatic stellate cells in the ﬁbrotic zone (10·).
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ity in samples treated with urea up to 4 M concentration
(Fig. 4A), which subsequently disappears from 4.5 M urea
treatment and onward (Fig. 4B). Conformational changes in
sera albumin at 3, 4 and 5 M of urea in control and ﬁbrotic rats
are shown in Fig. 5A and B, respectively. A distinct peak at
272 nm was observed that essentially shows perturbation
range of tyrosine residues. Compared to the control, spectra
of urea- treated albumin samples of ﬁbrotic rat showed lower
DA values and no shift in spectral peak (Fig. 5A and B).
Immunoblotting data on the urea-treated albumin samples
from control and progressive ﬁbrotic stages clearly display a
signiﬁcant decline in the intensity of puriﬁed bands, indicative
of hypoalbuminemia during hepatic ﬁbrosis in rats (Fig. 5C).4. Discussion
Serum, an important component of blood, lacks blood cells
(red or white), clotting factors and ﬁbrinogens. It comprises
immunoglobulins, antigens, hormones, electrolytes along with
other exogenous substances. It is regarded as the best source
for proteomic analyses and hence, used in various diagnostic
tests as a non-invasive source in many pathophysiological con-
ditions (Adkins et al., 2002; Ahmad et al., 2008; Madian and
Regnier, 2010). The major protein in the serum, constituting
about 50%, is albumin, a globular protein of nearly 65–
67 kD (Hasnain et al., 2004; Ahmad et al., 2007, 2011a). Albu-
min is synthesized in the liver as a precursor- preproalbuminPlease cite this article in press as: Ahmad, A., Ahmad, R. In-gel detection of estera
putative role as non-invasive biomarker of hepatic ﬁbrosis. Arabian Journal of Cheand with N-terminal peptide, which during post-translational
processing of the nascent protein is removed in the rough
endoplasmic reticulum. Subsequent to cleavage of proalbumin
in Golgi vesicles, albumin is secreted out. That albumin exhib-
its esterase-like activity has been a matter of great interest due
to the potential of albumin as a candidate biomarker in several
diseases (Dubois-Presle et al., 1995; Salvi et al., 1997; Sakurai
et al., 2004). It is already established that esterase-like albumin
activity of human serum albumin (HSA) is attributed to sub-
domain IIIA (Watanabe et al., 2000). NMR spectroscopy data
and site-directed mutagenesis studies revealed signiﬁcantly
augmented rates of hydrolysis of aspirin in the presence of
HSA, thereby conﬁrming the esterase-like activity of HSA
(at site I) and the role of Arg-410 and Tyr-411 for the esterase
activity of HSA (Hawkins et al., 1969; Burch and Blazer-Yost,
1981; Honma and Ishikawa, 1991; Watanabe et al., 2000).
Since serum contains adequate amount of esterases which
are involved in drug metabolism (Hubbard et al., 2008;
Ahmad et al., 2012), their levels along with esterase-like albu-
min activity have been employed as prognostic markers for
various diseases (Aoyagi et al., 1984; Ahmad et al., 2011a,
2011b, 2012; Thangthaeng et al., 2011). In the present study,
we analyzed the major sera protein fractions, in-gel histochem-
ical staining for esterase-like albumin activity, and puriﬁcation
of serum albumin (from all treatment groups) by electroelution
followed by its molecular weight estimation and UV-spectros-
copy. Further we have analyzed the albumin activity in urea-
treated protein samples of control and ﬁbrotic rats by
immunoblotting.se-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
Figure 2 Electrophoretic studies of rat sera. Native polyacrylamide gel electrophoretic (PAGE) proﬁles of control (C) and ﬁbrotic (F) rat
sera samples [A] CBBR staining [B] Esterase staining. SDS–PAGE proﬁles of control (C) rat sera and puriﬁed albumin samples (pAlb). [C]
CBBR staining, [D] Esterase staining. [E] Gel portion showing esterase-like albumin activity zone in control and ﬁbrotic animals and their
relative intensity.
6 A. Ahmad, R. AhmadN0-Nitrosodimethyl amine-induced hepatic ﬁbrosis in rats,
an established model in our laboratory (Ahmad et al., 2009,
2012, 2014; Ahmad and Ahmad, 2014), was conﬁrmed by
H&E staining along with the immunohistochemical staining
of a-smooth muscle actin (diagnostic marker of hepatic stellate
cell activation) (Fig. 1). We have used the ﬁbrotic rat model to
authenticate our approach of albumin characterization during
diseased state. The protein types (s), in their normal conforma-
tion, were identiﬁed by native gels run under non-denaturing
conditions. Since native gel electrophoresis does not use a
charged denaturant, the proteins being separated experience
different electrophoretic forces dependent on the shape of
the overall structure and may be visualized by general protein
staining as well as by substrate speciﬁc (enzyme) staining
(Ahmad et al., 2008, 2011b). Our results demonstrate at least
ﬁve major activity zones of varying intensity in control and
ﬁbrotic animals, namely: globulins, haptoglobins, transferrins,
albumin and prealbumin along with the identiﬁcation of
esterase-like albumin activity in the whole sera of rats
(Fig. 2A and B).
The electroeluted and puriﬁed albumin resolved as single
band on SDS–PAGE also shows almost comparable ester-
ase-like albumin activity on native gels in control and ﬁbrotic
rats (Fig. 2C). Therefore, the present approach provides aPlease cite this article in press as: Ahmad, A., Ahmad, R. In-gel detection of estera
putative role as non-invasive biomarker of hepatic ﬁbrosis. Arabian Journal of Cheuseful and convenient method for studying oxidative modiﬁca-
tion and a variety of post-translational modiﬁcations of sera
albumin.
Esterase-like activity of albumin can be visualized by sub-
strate staining with a-, and b-naphthyl acetate in the presence
of Fast Blue RR salt as a dye coupler (Ahmad et al., 2012).
Albumin preparations have been found to hydrolyze many
xenobiotic esters. The term ‘esterase-like’ activity of albumin
has been introduced to explain these observations. In some cases
however, it is still not clear if this activity is intrinsic to the
albumin molecule or is in fact due to contamination of esterase
impurity in the albumin preparation. Chapuis et al. (2001) had
previously demonstrated that esterase-like albumin activity in
humans is due to contamination of low amounts of other
esterases. In our conditions, the esterase-like albumin activity
was detected with almost equal intensity in control as well as
ﬁbrotic animals (Fig. 2C), signifying the sensitivity of the native
PAGE. During electrophoretic separation of serum proteins
under native conditions, albumin, due to its net negative charge,
migrates toward the anode. The present system may offer sepa-
ration of proteins with higher electrophoretic mobility than
albumin in relatively more concentrated gels (with smaller pore
size) andmay prove suitable for separation ofmultiplex proteins
also (Yan et al., 2007). Further our SDS–PAGE results of these-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
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Figure 3 Characterization of puriﬁed albumin. [A] SDS–PAGE Proﬁle: M, MW marker (chicken actomyosin); C, control sera samples;
F, sera from ﬁbrotic animal; pAlb-C, puriﬁed albumin from control rat and pAlb-F, puriﬁed albumin from ﬁbrotic animal. [B] peptide
mass ﬁngerprint (PMF)/MS spectrum generated by tryptic digestion of rat serum albumin.
Esterase-free albumin and its signiﬁcance 7puriﬁed albumin demonstrate the presence of single band of
albumin that stacks corresponding to Mr 66 kD, in control
as well as ﬁbrotic sera samples (Fig. 3A). Our MS results
(Fig. 3B) are also indicative of purity of the preparation (albu-
min) and the sensitivity of the technique adopted.Please cite this article in press as: Ahmad, A., Ahmad, R. In-gel detection of estera
putative role as non-invasive biomarker of hepatic ﬁbrosis. Arabian Journal of CheUrea is the most popular denaturant, being used extensively
in biochemistry, not only to denature protein at higher concen-
trations, but also to promote controlled folding. Perhaps the
most widely studied model of globular proteins is serum albu-
min, synthesized by the liver, accounting for 60% of the totalse-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
Figure 5 Characterization of albumin during hepatic ﬁbrosis. UV difference spectra of puriﬁed albumin between 250 and 300 nm. [A]
Albumin puriﬁed from control/untreated rat sera, [B] Albumin puriﬁed from ﬁbrotic rat sera. [C] Immunoblots of puriﬁed albumin in
control and NDMA treated samples of rat. Bar graph showing quantitative variations in the expression of albumin protein obtained
during Western immunoblots.
Figure 4 Urea denaturation of puriﬁed albumin. Native PAGE proﬁle of urea-denatured puriﬁed albumin. Control rat sera (1); Puriﬁed
albumin from ﬁbrotic animal with increasing molarities of Urea: [A] (2) 1 M, (3) 2 M, (4) 3 M, (5) 3.5 M, (6) 4 M; [B] (2) 4.5 M and (3) 5 M
urea concentration.
8 A. Ahmad, R. Ahmadglobular proteins in blood plasma and constituted by around
585 amino acid residues, whereas its secondary structure is
constituted by 67% alpha helix and 17 disulﬁde bridges that
confer to the protein a relatively strong stability (Carter and
Ho, 1994). An interesting study by Itri et al. (2004) shows that
the presence of 3 M urea induces folding in BSA (revealed byPlease cite this article in press as: Ahmad, A., Ahmad, R. In-gel detection of estera
putative role as non-invasive biomarker of hepatic ﬁbrosis. Arabian Journal of CheSAXS) and its secondary structure remains almost unaltered in
terms of helicity as evidenced by CD data. On the other hand,
5 M urea showed pronounced effect on protein structure: the
a-helical content suffers a remarkable decrease accompanied
by a signiﬁcant change in protein conformational as revealed
by the values observed for macromolecule radius of gyrationse-like albumin activity: Characterization of esterase-free sera albumin and its
mistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.10.016
Esterase-free albumin and its signiﬁcance 9(Rg = 72 A˚) and maximum dimension (Dmax = 240 A˚) as well
as from functional behavior. Moreover, the above cited study
also demonstrate that addition of 3 and 5 M urea in equal con-
centration of BSA, slightly decreases the tryptophan emission,
suggesting that urea unfolds the protein in the interface. Gull
et al. (2007) reports that in case of urea-induced unfolding of
HSA, domain III is primarily responsible for intermediate for-
mation, wherein domains I and III unfold before 5 M and
domain II unfolds beyond it. Moreover, the presence of a sin-
gle cysteine, tryptophan and tyrosine residue in domains I, II
and III respectively, offers a chance to pursue the unfolding
and refolding studies. Subdomain IIIA of HSA possesses a
well known esterase-like activity toward substrates such as p-
nitrophenyl acetate and several N-carbobenzoxy-D(L)-alanine
p-nitrophenyl esters (Watanabe et al., 2000).
Our results based on electrophoretic proﬁling and spectros-
copy data on urea induced changes in esterase-like albumin
activity are in conformity with the above cited reports and
clearly demonstrate that at >4 M urea concentrations ester-
ase-like albumin activity is completely abolished (Fig. 4A
and B). The present results, however, partially contradict the
ﬁndings of Thangthaeng et al. (2011), wherein esterase-like
albumin activity was not detectable in the samples with
P2 M urea concentrations. It is intriguing that in our case,
similar to HSA, the esterase like albumin activity in rat sera
albumin is located in domain-III, which is detectable appar-
ently due to unfolding of protein up to 4 M urea and later,
diminishes on increasing the urea concentration (Fig. 5A and
B). Now it is evident that rat serum albumin obtained from
the control and ﬁbrotic rats shows resistance up to 4 M
urea-treatment implying the stability and sensitivity of esterase
binding domain of albumin at 64 M. Moreover, immuno
blotting (Fig. 5C) of 4.5 M treated albumin sample reveals a
signiﬁcant decline in sera albumin concentration or hypoalbu-
minemia during progressive hepatic ﬁbrosis.5. Concluding remarks
Since sera albumin is taken as a non-invasive biomarker in
most of the diseases, its characterization is essential in those
conditions where there is an apparent controversy on albumin
levels. In this communication, we demonstrate a methodical
approach of albumin puriﬁcation and its subsequent character-
ization using various techniques such as MALDI-TOF/MS,
spectroscopy and Western immunoblotting. It is concluded
that the inhibition of esterase-like albumin activity by urea-
treatment may be a potential approach for accurate albumin
estimation particularly in cases where probability of esterase
contamination is high. Furthermore, puriﬁcation and charac-
terization of albumin during hepatic ﬁbrosis suggest hypoalbu-
minemia and supports its putative role for diagnostic purposes
in addition to other non-invasive disease biomarkers.
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